November 2011

IDIBELL is among the 120 top research centers in the world

Leave a Comment / Sin categorizar / By

The Scimago international ranking of Research Institutions places IDIBELL on 115th position among the 500 most highly-rated institutions in the world in all disciplines by its index and normalized impact with an excellence rate of 27.3. The report analyzes the scientific articles published by more than three thousand institutions in 104 different countries between 2005 […]

IDIBELL is among the 120 top research centers in the world Read More »

Ferran Azorín: “Knowledge of basic mechanisms of epigenetics will allow us to develop new therapeutic strategies”

Leave a Comment / Sin categorizar / By

The laboratory of the Molecular Biology Institute of the CSIC in Barcelona led by Ferran Azorin, focuses its research on trying to understand the basic mechanisms that regulate genome function through epigenetics. The researcher has explained its latest advances in this field in the IDIBELL seminar series on November 25. One of the epigenetic factors

Ferran Azorín: “Knowledge of basic mechanisms of epigenetics will allow us to develop new therapeutic strategies” Read More »

Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer”

Leave a Comment / Sin categorizar / By

The researcher at INSERM (French Institute for Health and Medical Research) Jean-Ehrland Ricci examines the correlation between glycolysis, cell death and immune response in tumor cells. He explained his latest developments in his research on IDIBELL seminar series November 18. Most cancer cells exhibit increased glycolysis for the generation of their energy supply (named the

Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer” Read More »

Described a new molecular mechanism altered in breast cancer development

Leave a Comment / Breast cancer, Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

About 10% of breast cancers are due to mutations in genes called BRCA1 and BRCA2. Still, it is not yet fully known the molecular mechanism that explains how the alteration of these genes greatly increases the risk of cancer. An international team led by the researcher of the IDIBELL and the Catalan Institute of Oncology

Described a new molecular mechanism altered in breast cancer development Read More »

Louis Bouscail: “Our research in gene therapy must advance step by step. Our next challenge is to reach phase II of our clinical trial”

Leave a Comment / Uncategorised / By

The gastroenterologist of the University Hospital of Rangueil, Touluse, and researcher at INSERM, Louis Buscail explained his latest advances in gene therapy for advanced pancreatic cancer in IDIBELL seminar series on 11 November. Currently, the only effective treatment for pancreatic cancer is surgery. The chemotherapeutic agent gemcitabine improves the survival of the patient but survival

Louis Bouscail: “Our research in gene therapy must advance step by step. Our next challenge is to reach phase II of our clinical trial” Read More »

La Marató de TV3 finance five projects involving IDIBELL researchers

Leave a Comment / Cancer, Cellular and Molecular Neurobiology , Cognition and Brain Plasticity, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Neuroscience Area, Neuroscience Program, Preclinical and experimental research in thoracic tumors / By

Five IDIBELL researchers are involved in projects funded by La Marató de TV3, dedicated to spinal cord and acquired brain injuries. They are María Berdasco, research group of Cancer Epigenetics; Artur Llobet, research group of celular and Molecular Neurobiology; Cristina Muñoz Pinedo, head of the research group of Cell Death regulation; Antoni Rodríguez-Fornells, head of

La Marató de TV3 finance five projects involving IDIBELL researchers Read More »

The therapeutic videogame realized by IDIBELL researchers, one of the best ideas of the year for ‘Diario Médico’

Leave a Comment / Neuroscience Area, Neuroscience Program, Psychoneurobiology of Eating and Addictive Behaviours / By

The IDIBELL and the University Hospital of Bellvitge have received one of the awards to the Best Ideas of the Year, awarded by the newspaper specializing in medicine and health ‘Diario Médico’, for their therapeutic videogame, called Islands, directed to complement the therapy of patients with eating disorders or pathological gambling addiction. This is the

The therapeutic videogame realized by IDIBELL researchers, one of the best ideas of the year for ‘Diario Médico’ Read More »

Ben Lehner: Why would a mutation kill me, but not you?”

Leave a Comment / Uncategorised / By

This is the big question that drives all the research in the laboratory of Genetic Systems directed by the ICREA researcher Ben Lehner at the Center for Genomic Regulation in Barcelona. Lehner explained their latest findings on an IDIBELL seminar on November 4th. Lehner’s group seeks to understand why two genetically identical individuals, which have

Ben Lehner: Why would a mutation kill me, but not you?” Read More »

Scroll to Top